Active, not recruitingNCT04342715

A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of York
Principal Investigator
Paul Kaye, PhD
University of York
Intervention
Sodium stibogluconate / paramomycin(drug)
Enrollment
216 target
Eligibility
12-50 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

University of Gondar · Kenya Medical Research Institute · Makerere University · University of Khartoum · European Vaccine Initiative · European and Developing Countries Clinical Trials Partnership (EDCTP)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04342715 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials